Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 2.58 CAD 3.2% Market Closed
Market Cap: 118.6m CAD
Have any thoughts about
Theratechnologies Inc?
Write Note

Relative Value

The Relative Value of one TH stock under the Base Case scenario is 4.05 CAD. Compared to the current market price of 2.58 CAD, Theratechnologies Inc is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TH Relative Value
Base Case
4.05 CAD
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
88
Median 3Y
1
Median 5Y
10.1
Industry
7.6
Forward
1
vs History
vs Industry
Median 3Y
-9.1
Median 5Y
-24.9
Industry
22.1
Forward
49.8
vs History
vs Industry
Median 3Y
-37
Median 5Y
-62.6
Industry
21.9
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-36.4
Industry
23.4
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-0.5
Industry
2.5
vs History
90
vs Industry
78
Median 3Y
1.1
Median 5Y
10.2
Industry
7.5
Forward
0.9
vs History
90
vs Industry
74
Median 3Y
1.4
Median 5Y
17.1
Industry
9.3
vs History
9
vs Industry
9
Median 3Y
-6.4
Median 5Y
-31.7
Industry
4.2
Forward
4.3
vs History
6
vs Industry
6
Median 3Y
-4.4
Median 5Y
-23.3
Industry
4
Forward
6.5
vs History
vs Industry
Median 3Y
-35.5
Median 5Y
-64.3
Industry
5.9
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-59.4
Industry
3.9
vs History
82
vs Industry
22
Median 3Y
9.7
Median 5Y
16.4
Industry
4.5

Multiples Across Competitors

TH Competitors Multiples
Theratechnologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Theratechnologies Inc
TSX:TH
118.6m CAD 1 -26.1 6.7 8.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 142 781.8 -181 287 -220 140.1 -217 628.1
US
Abbvie Inc
NYSE:ABBV
315.2B USD 5.7 62 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
141.9B USD 4.4 33.5 16.1 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
116.4B USD 4.1 923.6 10.3 10.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.5B USD 9.8 -217.7 21.5 22.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 847 -471.3 -513.3 -499.6
AU
CSL Ltd
ASX:CSL
135.7B AUD 5.7 32.1 19.9 24.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 5.7 16.9 15.4 17.1
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.6 -52.9
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -135.3 -109.3 -79.6
P/S Multiple
Revenue Growth P/S to Growth
CA
Theratechnologies Inc
TSX:TH
Average P/S: 3 467 700.2
1
20%
0
FR
Pharnext SCA
OTC:PNEXF
38 142 781.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.8
34%
0.3
US
E
Epizyme Inc
F:EPE
1 847
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
CA
Theratechnologies Inc
TSX:TH
Average P/E: 213.6
Negative Multiple: -26.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 287 N/A N/A
US
Abbvie Inc
NYSE:ABBV
62
413%
0.2
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
923.6
77%
12
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -217.7
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -471.3 N/A N/A
AU
CSL Ltd
ASX:CSL
32.1
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Theratechnologies Inc
TSX:TH
Average EV/EBITDA: 15
6.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -220 140.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16.1
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.5
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -513.3 N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Theratechnologies Inc
TSX:TH
Average EV/EBIT: 19.7
8.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 628.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.6
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -499.6 N/A N/A
AU
CSL Ltd
ASX:CSL
24.8
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -52.9 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.6 N/A N/A

See Also

Discover More
Back to Top